SECURITY AGREEMENTSecurity Agreement • April 13th, 2007 • Inhibitex, Inc. • Biological products, (no disgnostic substances) • New York
Contract Type FiledApril 13th, 2007 Company Industry JurisdictionThis SECURITY AGREEMENT (this “Agreement”), dated as of April 9, 2007, by FERMAVIR PHARMACEUTICALS, INC., a Florida corporation (“FPI”) and FERMAVIR RESEARCH, INC., a Delaware corporation (“FRI”, each of FPI and FRI is referred to herein individually as a “Grantor” and collectively as the “Grantors”), and INHIBITEX, INC., a Delaware corporation (the “Purchaser” or the “Collateral Agent”), as Collateral Agent on behalf of the Holders (as defined herein).
COMPANY VOTING AGREEMENTCompany Voting Agreement • April 13th, 2007 • Inhibitex, Inc. • Biological products, (no disgnostic substances) • Delaware
Contract Type FiledApril 13th, 2007 Company Industry JurisdictionCOMPANY VOTING AGREEMENT (this “Agreement”) dated as of April , 2007, by and between INHIBITEX, INC., a Delaware corporation (“Parent”), and the Stockholders of FERMAVIR PHARMACEUTICALS, INC., a Florida corporation (the “Company”), whose signatures appear on the signature pages to this Agreement (each a “Stockholder”). Capitalized terms used and not otherwise defined herein shall have the meanings given to such terms in the Merger Agreement (as defined herein).